The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/12230594
Conclusion of this study
MIG-99 was shown to be effective only in a small predefined subgroup of patients with at least four attacks during the 28-day baseline period where the most favourable benefit-risk ratio was observed with a dosage of three capsules of 6.25 mg MIG-99 extract per day.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study